Engineers Gate Manager’s Ascendis Pharma A/S ASND Stock Holding History

Engineers Gate Manager’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.57M	Buy	9,648 +18	+0.2%	+$4.21K	0.03%	588
2026 Q1	$2.2M	Buy	9,630 +2,152	+29%	+$482K	0.03%	681
2025 Q4	$1.59M	Sell	7,478 -3,702	-33%	-$765K	0.02%	813
2025 Q3	$2.22M	Sell	11,180 -514	-4%	-$95.9K	0.03%	716
2025 Q2	$2.02M	Sell	11,694 -91	-0.8%	-$14.8K	0.03%	730
2025 Q1	$1.84M	Buy	11,785 +5,052	+75%	+$722K	0.03%	727
2024 Q4	$927K	Buy	6,733 +2,472	+58%	+$325K	0.02%	1060
2024 Q3	$636K	Sell	4,261 -2,842	-40%	-$384K	0.01%	1267
2024 Q2	$969K	Buy	7,103 +627	+10%	+$85.3K	0.02%	901
2024 Q1	$979K	Buy	+6,476	New	+$924K	0.03%	839
2023 Q1	–	Sell	-5,368	Closed	-$656K	–	1638
2022 Q4	$656K	Buy	+5,368	New	+$623K	0.04%	739
2020 Q2	–	Sell	-1,970	Closed	-$222K	–	1680
2020 Q1	$222K	Buy	+1,970	New	+$256K	0.02%	1201
2019 Q4	–	Sell	-4,491	Closed	-$433K	–	1608
2019 Q3	$433K	Buy	+4,491	New	+$501K	0.02%	845

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Engineers Gate Manager's ASND Position: Q2 2026 in Review

Engineers Gate Manager increased its Ascendis Pharma A/S (ASND) stake by 0.19% in Q2 2026, buying an estimated $4.21K and bringing the position to 9,648 shares worth $2.57M. The position accounts for 0.03% of the portfolio, ranked #588.

Engineers Gate Manager first reported a position in ASND in Q3 2019 and has held it in 13 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Engineers Gate Manager held 9,648 shares of Ascendis Pharma A/S worth $2.57M as of Q2 2026.
Engineers Gate Manager bought 18 Ascendis Pharma A/S shares in Q2 2026, an estimated $4.21K.
Ascendis Pharma A/S made up 0.03% of Engineers Gate Manager's portfolio in Q2 2026, its #588 holding.
Engineers Gate Manager first reported a position in Ascendis Pharma A/S in Q3 2019 and has held it in 13 quarters since.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.